beta

CEMI

Chembio Diagnostics, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY.

Market Cap: 219 Million

Primary Exchange: NASDAQ

Website: http://www.chembio.com

Shares Outstanding: 20.2 Million

Float: 17 Million

Dividend: (%)

Beta: 0.12173828369072

Sector: Health Technology

Industry: Medical Specialties

Ethical Flags

Longest drawdown: 782 trading days

From: 2013-02-15 To: 2016-03-29

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud